High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy
- 1 May 2001
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 67 (2), 111-116
- https://doi.org/10.1023/a:1010619225209
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase ii multicentre multinational studyEuropean Journal Of Cancer, 1997
- Pharmacology of new aromatase inhibitorsThe Breast, 1996
- Breast cancer: Chemotherapy in the treatment of advanced diseaseEuropean Journal Of Cancer, 1993
- Response to third-line endocrine treatment for advanced breast cancerEuropean Journal Of Cancer, 1993
- Randomized trial of estrogen vs. tamoxifen therapy for advanced breast cancerAmerican Journal of Clinical Oncology, 1985
- Randomized Clinical Trial of Diethylstilbestrol versus Tamoxifen in Postmenopausal Women with Advanced Breast CancerNew England Journal of Medicine, 1981
- Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.BMJ, 1975
- SYNTHETIC ŒSTROGENS IN MAMMARY CANCERThe Lancet, 1949
- Influence of Synthetic Oestrogens on Advanced Malignant DiseaseBMJ, 1944
- Regression of Tumours following Treatment by Stilbœstrol and X-ray Therapy, with Notes on a Case of Breast Tumour which regressed with Stilbœstrol aloneThe British Journal of Radiology, 1944